Zoloft (sertraline) is one of the most commonly prescribed antidepressants in the United States. Many individuals taking Zoloft are concerned about whether it will appear on a drug test or cause a false positive.
In most cases, Zoloft will not show up on a drug test.
What Drug Tests Actually Detect
Standard drug tests, including those regulated by the DOT, screen for specific categories of drugs:
- Marijuana
- Cocaine
- Amphetamines
- Opiates
- PCP
Zoloft is a selective serotonin reuptake inhibitor (SSRI) and does not fall into any of these categories.
Therefore, it is not included in standard drug testing panels.
Can Zoloft Cause a False Positive?
Although rare, Zoloft has been reported to cause false positives for benzodiazepines in some older screening tests.
This happens because immunoassay tests can occasionally mistake one compound for another based on structural similarities.
However, modern drug testing protocols include confirmation testing, which eliminates these false positives.
What Happens If There Is a False Positive?
If a screening test produces a non-negative result:
- The sample undergoes confirmation testing
- The specific substance is identified
- A Medical Review Officer verifies prescriptions
If Zoloft is the cause, the final result will be corrected and reported as negative.
Zoloft and DOT Medical Certification
While Zoloft does not affect drug test results, it may still be reviewed during a DOT medical exam.
Medical examiners evaluate whether medications:
- Affect alertness
- Cause drowsiness
- Impact decision-making
Zoloft is generally considered safe for many drivers, especially if they are stable on the medication.
Final Thoughts
Zoloft will not appear on a drug test and rarely causes issues in modern testing programs.
Key points include:
- It is not part of standard drug testing panels
- False positives are rare and corrected through confirmation testing
- It may be reviewed during DOT medical certification
Drivers and employees should always communicate openly about medications to ensure compliance and safety.